Testing effectiveness (Phase 2)Active Not RecruitingNCT05453500
What this trial is testing
Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
University of Washington 32